News

Monoamine oxidase inhibitors (MAOIs) are medications for depression. They take time to work but can be helpful along with other therapies and lifestyle changes. However, they have more side ...
Monoamine oxidase inhibitors (MAOIs) change the levels of the brain chemicals norepinephrine, serotonin and dopamine called neurotransmitters. Known as neurotransmitters, their job is to keep your ...
Medically reviewed by Steven Gans, MDMedically reviewed by Steven Gans, MD Monoamine oxidase inhibitors (MAOIs) are the oldest class of antidepressants. Although they have largely been replaced by ...
Monoamine oxidase inhibitors (MAOIs) have a long and prosperous history as medications for major depressive disorder (MDD). But this type of antidepressant has mostly seen its day.
a MAO-B = monoamine oxidase type B, MAO-A = monoamine oxidase type A. b Expressed as the molar concentration of drug required to inhibit enzyme activity by 50% (nmol/L).
The link was discovered in the 1950s when doctors began prescribing monoamine oxidase inhibitors (MAOIs) for depression. Some patients complained of headaches and symptoms of high blood pressure ...
SINCE iproniazid was shown to be an effective monoamine oxidase inhibitor by Zeller et al. 1 in 1952 there has been extensive use of monoamine oxidase inhibitors, particularly in psychiatric ...
Announcing a new publication for Acta Materia Medica journal. Monoamine oxidase (MAO) is a useful target in the treatment of neurodegenerative diseases and depressive disorders. Understanding the ...
WHILE investigating the role of histamine, serotonin and catecholamines in the pathogenesis of bacterial infections, we observed aggravation of the condition of infected animals previously treated ...
Monoamine oxidase inhibitors (MAOIs) have a long and prosperous history as medications for major depressive disorder (MDD). But this type of antidepressant has mostly seen its day.
Cite this: Rasagiline: A Second-Generation Monoamine Oxidase Type-B Inhibitor for the Treatment of Parkinson's Disease - Medscape - May 15, 2006. Abstract and Introduction Selective MAO-B ...